Edelman, Martin J <br/><br/>
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Nov 2016 
 - 959-967 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-016-3148-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Arsenic--blood<br/>Arsenites--administration & dosage<br/>Cisplatin--administration & dosage<br/>Endpoint Determination<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Humans<br/>Long QT Syndrome--chemically induced<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Platinum--blood<br/>Sodium Compounds--administration & dosage<br/>Telomerase--antagonists & inhibitors<br/>Treatment Outcome